A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

457

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Fluticasone Propionate/Formoterol Fumarate

Inhalation suspension for nebulization 1000/20 mcg bid for 2 weeks

DRUG

Fluticasone Propionate/Formoterol Fumarate

Inhalation Suspension for nebulization 1000/10 mcg bid for 2 weeks

DRUG

Fluticasone Propionate/Formoterol Fumarate

Inhalation Suspension for nebulization 500/20 mcg bid for 2 weeks

DRUG

Fluticasone Propionate/Formoterol Fumarate

Inhalation Suspension for nebulization 500/10 mcg bid for 2 weeks

DRUG

Fluticasone Propionate

Inhalation Suspension for nebulization 1000 mcg bid for 2 weeks

DRUG

Formoterol Fumarate

Inhalation Solution for nebulization 20 mcg bid for 2 weeks

DRUG

Fluticasone Propionate/Salmeterol Xinafoate

Inhalation Powder delivered by Diskus device 250/50 mcg bid for 2 weeks

DRUG

Placebo

Inhalation Solution for nebulization 2 mL bid for 2 weeks

Trial Locations (49)

13031

Research Site, Camillus

13088

Research Site, Liverpool

20902

Research Site, Wheaton

23225

Research Site, Richmond

24210

Research Site, Abingdon

27560

Research Site, Morrisville

27607

Research Site, Raleigh

28207

Research Site, Charlotte

29303

Research Site, Spartanburg

29615

Research Site, Greenville

30189

Research Site, Woodstock

30309

Research Site, Atlanta

32720

Research Site, DeLand

33321

Research Site, Tamarac

33603

Research Site, Tampa

33765

Research Site, Clearwater

35209

Research Site, Birmingham

35501

Research Site, Jasper

42431

Research Site, Madisonville

45227

Research Site, Cincinnati

45231

Research Site, Cincinnati

45242

Research Site, Cincinnati

53217

Research Site, Milwaukee

55402

Research Site, Minneapolis

60141

Research Site, Hines

63122

Research Site, St Louis

63301

Research Site, Saint Charles

66219

Research Site, Lenexa

66606

Research Site, Topeka

73104

Research Site, Oklahoma City

75231

Research Site, Dallas

78229

Research Site, San Antonio

78750

Research Site, Austin

80033

Research Site, Wheat Ridge

83814

Research Site, Coeur d'Alene

85006

Research Site, Phoenix

87108

Research Site, Albuquerque

89014

Research Site, Henderson

90095

Research Site, Los Angeles

90620

Research Site, Buena Park

92024

Research Site, Encinitas

92120

Research Site, San Diego

92626

Research Site, Costa Mesa

97213

Research Site, Portland

97504

Research Site, Medford

98405

Research Site, Tacoma

08003

Research Site, Cherry Hill

02914

Research Site, East Providence

05403

Research Site, South Burlington

All Listed Sponsors
lead

Dey

INDUSTRY

NCT00403286 - A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter